Tomer Gold

Director Técnico/Científico/I+D en Dexcel Pharma Technologies Ltd. .

52 años

Health Technology

Consumer Services

Cargos activos de Tomer Gold

Empresas	Cargo	Inicio	Fin
Dexcel Pharma Technologies Ltd. Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.	Director Técnico/Científico/I+D	01/01/2011	-

Empresas	Cargo	Inicio	Fin
CYNAPSUS THERAPEUTICS INC	Director/Miembro de la Junta	09/05/2013	21/10/2016
CYNAPSUS THERAPEUTICS INC	Independent Dir/Board Member	04/08/2014	21/10/2016

Technion-Israel Institute of Technology

Graduate Degree

Internacional

Israel	3
Canadá	2

Operativa

Director/Board Member	1
Independent Dir/Board Member	1
Graduate Degree	1

Sectorial

Health Technology	3
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	2
Cynapsus Therapeutics, Inc. Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada.	Health Technology
Dexcel Pharma Technologies Ltd. Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.	Health Technology